257 related articles for article (PubMed ID: 26965996)
1. Prostate-derived ets factor represses tumorigenesis and modulates epithelial-to-mesenchymal transition in bladder carcinoma cells.
Tsui KH; Lin YH; Chung LC; Chuang ST; Feng TH; Chiang KC; Chang PL; Yeh CJ; Juang HH
Cancer Lett; 2016 May; 375(1):142-151. PubMed ID: 26965996
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of prostate-derived Ets factor by luteolin causes inhibition of cell proliferation and cell invasion in prostate carcinoma cells.
Tsui KH; Chung LC; Feng TH; Chang PL; Juang HH
Int J Cancer; 2012 Jun; 130(12):2812-23. PubMed ID: 21780100
[TBL] [Abstract][Full Text] [Related]
3. Growth differentiation factor-15: a p53- and demethylation-upregulating gene represses cell proliferation, invasion, and tumorigenesis in bladder carcinoma cells.
Tsui KH; Hsu SY; Chung LC; Lin YH; Feng TH; Lee TY; Chang PL; Juang HH
Sci Rep; 2015 Aug; 5():12870. PubMed ID: 26249737
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms by which interleukin-6 attenuates cell invasion and tumorigenesis in human bladder carcinoma cells.
Tsui KH; Wang SW; Chung LC; Feng TH; Lee TY; Chang PL; Juang HH
Biomed Res Int; 2013; 2013():791212. PubMed ID: 23762858
[TBL] [Abstract][Full Text] [Related]
5. Metallothionein 3 Is a Hypoxia-Upregulated Oncogene Enhancing Cell Invasion and Tumorigenesis in Human Bladder Carcinoma Cells.
Tsui KH; Hou CP; Chang KS; Lin YH; Feng TH; Chen CC; Shin YS; Juang HH
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30813460
[TBL] [Abstract][Full Text] [Related]
6. Prostate-derived ETS factor improves prognosis and represses proliferation and invasion in hepatocellular carcinoma.
Chen EB; Zhou SL; Pang XG; Yin D; Miao PZ; Yang Y; Chen Q; Zhu K; Gao DM; Liu TS; Wang XY; Shi YH; Wu WZ; Zhou J; Zhou ZJ; Dai Z
Oncotarget; 2017 Aug; 8(32):52488-52500. PubMed ID: 28881746
[TBL] [Abstract][Full Text] [Related]
7. N-myc downstream-regulated gene 1 downregulates cell proliferation, invasiveness, and tumorigenesis in human oral squamous cell carcinoma.
Lee JC; Chung LC; Chen YJ; Feng TH; Juang HH
Cancer Lett; 2014 Dec; 355(2):242-52. PubMed ID: 25218595
[TBL] [Abstract][Full Text] [Related]
8. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.
Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL
Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949
[TBL] [Abstract][Full Text] [Related]
9. Down-regulating ribonuclease inhibitor enhances metastasis of bladder cancer cells through regulating epithelial-mesenchymal transition and ILK signaling pathway.
Xiong D; Liou Y; Shu J; Li D; Zhang L; Chen J
Exp Mol Pathol; 2014 Jun; 96(3):411-21. PubMed ID: 24768914
[TBL] [Abstract][Full Text] [Related]
10. CRISPR/Cas9-mediated knockout of the PDEF gene inhibits migration and invasion of human gastric cancer AGS cells.
Zhang YQ; Pei JH; Shi SS; Guo XS; Cui GY; Li YF; Zhang HP; Hu WQ
Biomed Pharmacother; 2019 Mar; 111():76-85. PubMed ID: 30576937
[TBL] [Abstract][Full Text] [Related]
11. Novel role for PDEF in epithelial cell migration and invasion.
Gunawardane RN; Sgroi DC; Wrobel CN; Koh E; Daley GQ; Brugge JS
Cancer Res; 2005 Dec; 65(24):11572-80. PubMed ID: 16357167
[TBL] [Abstract][Full Text] [Related]
12. Slug contributes to cadherin switch and malignant progression in muscle-invasive bladder cancer development.
Wu K; Zeng J; Zhou J; Fan J; Chen Y; Wang Z; Zhang T; Wang X; He D
Urol Oncol; 2013 Nov; 31(8):1751-60. PubMed ID: 22421353
[TBL] [Abstract][Full Text] [Related]
13. A novel role of ribonuclease inhibitor in regulation of epithelial-to-mesenchymal transition and ILK signaling pathway in bladder cancer cells.
Yao X; Li D; Xiong DM; Li L; Jiang R; Chen JX
Cell Tissue Res; 2013 Sep; 353(3):409-23. PubMed ID: 23703635
[TBL] [Abstract][Full Text] [Related]
14. Reduced PDEF expression increases invasion and expression of mesenchymal genes in prostate cancer cells.
Gu X; Zerbini LF; Otu HH; Bhasin M; Yang Q; Joseph MG; Grall F; Onatunde T; Correa RG; Libermann TA
Cancer Res; 2007 May; 67(9):4219-26. PubMed ID: 17483333
[TBL] [Abstract][Full Text] [Related]
15. Prostate derived ETS factor (PDEF): a putative tumor metastasis suppressor.
Steffan JJ; Koul HK
Cancer Lett; 2011 Nov; 310(1):109-17. PubMed ID: 21764212
[TBL] [Abstract][Full Text] [Related]
16. AR-PDEF pathway promotes tumour proliferation and upregulates MYC-mediated gene transcription by promoting MAD1 degradation in ER-negative breast cancer.
Cao L; Xu C; Xiang G; Liu F; Liu X; Li C; Liu J; Meng Q; Jiao J; Niu Y
Mol Cancer; 2018 Sep; 17(1):136. PubMed ID: 30217192
[TBL] [Abstract][Full Text] [Related]
17. Signatures of prostate-derived Ets factor (PDEF) in cancer.
Mahajan N
Tumour Biol; 2016 Nov; 37(11):14335-14340. PubMed ID: 27612480
[TBL] [Abstract][Full Text] [Related]
18. PDEF downregulates stathmin expression in prostate cancer.
Sabherwal Y; Mahajan N; Helseth DL; Gassmann M; Shi H; Zhang M
Int J Oncol; 2012 Jun; 40(6):1889-99. PubMed ID: 22378487
[TBL] [Abstract][Full Text] [Related]
19. Tumor metastasis suppressor functions of Ets transcription factor through integrin β3-mediated signaling pathway.
Pal M
J Cell Physiol; 2019 Nov; 234(11):20266-20274. PubMed ID: 30982973
[TBL] [Abstract][Full Text] [Related]
20. Transgelin, a p53 and PTEN-Upregulated Gene, Inhibits the Cell Proliferation and Invasion of Human Bladder Carcinoma Cells in Vitro and in Vivo.
Tsui KH; Lin YH; Chang KS; Hou CP; Chen PJ; Feng TH; Juang HH
Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31591355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
